These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7242318)

  • 41. [What is the value of organic nitrate preparations in treatment of chronic heart failure?].
    Internist (Berl); 1996 Jul; 37(7):739. PubMed ID: 8830005
    [No Abstract]   [Full Text] [Related]  

  • 42. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
    Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
    Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 44. Is isosorbide mononitrate better than the dinitrate?
    Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
    Wiechmann HW; Schuster P; Trieb G
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
    Wiechmann HW; Schuster P; Trieb G
    Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
    [No Abstract]   [Full Text] [Related]  

  • 49. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
    Bergbauer M
    Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
    [No Abstract]   [Full Text] [Related]  

  • 50. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
    Bogaert MG; Rosseel MT; Boelaert J; Daneels R
    Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Nitrite and methemoglobin formation in dogs following oral isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate].
    Strein K; Dietmann K; Bartsch W
    Med Welt; 1981 Apr; 32(14A):499-502. PubMed ID: 7242308
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
    Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
    Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
    [No Abstract]   [Full Text] [Related]  

  • 53. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.
    Franciosa JA; Goldsmith SR; Cohn JN
    Am J Med; 1980 Oct; 69(4):559-66. PubMed ID: 7424945
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 55. Vasodilator therapy for congestive heart failure--new use for old drugs.
    McAlpin RN
    JAMA; 1978 Aug; 240(5):461-2. PubMed ID: 660892
    [No Abstract]   [Full Text] [Related]  

  • 56. [Previous history and principles of the development of isosorbide-5-mononitrate (IS-5-MN)].
    Schaumann W
    Med Welt; 1981 Apr; 32(14A):479-80. PubMed ID: 7242305
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
    Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
    Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
    [No Abstract]   [Full Text] [Related]  

  • 58. Isosorbide dinitrate oral spray in acute exacerbation of chronic congestive heart failure secondary to coronary artery disease.
    Marmor A; Schneeweiss A; Plich M; Blondheim D; Sharir T; Alpert JS
    Am J Cardiol; 1987 May; 59(12):1199-200. PubMed ID: 3578062
    [No Abstract]   [Full Text] [Related]  

  • 59. Frusemide or isosorbide dinitrate for acute heart failure?
    Lancet; 1983 May; 1(8333):1108-9. PubMed ID: 6133141
    [No Abstract]   [Full Text] [Related]  

  • 60. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
    Jost S
    Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.